Lymphoma and Myeloma Hematology Grand Rounds

---

RSS

Occurs monthly on the 4th Wednesday starting on 1/22/2025 at 8:00 AM
Wednesday, January 22, 2025, 8:00 AM - 9:00 AM, Virtual


AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance (1.00 hours)

The Lymphoma-Myeloma Grand Rounds activity is essentially a deep dive into hematologic malignancies. A educational platform that will explore pathophysiology, cutting-edge treatments, and the impact on patients' well-being. This will enhance a learner's understanding and improve outcomes for those affected by these diseases.

1. Comprehensively describe the current treatment options available for lymphoma and myeloma, including the latest therapeutic advancements, targeted therapies, immunotherapies, and their associated benefits and risks.
2. Evaluate the role of precision medicine in the treatment of blood cell cancers, specifically lymphoma and myeloma.
3. Assess the current landscape of emerging therapies and ongoing clinical trials for lymphoma and myeloma, examining the rationale behind these novel treatments, patient eligibility criteria, and evaluating the potential impact on the future management of blood cell cancers.

If you are interested in attending this series contact Lisa Foucheaux-Heider at [email protected]

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

 

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Date	Empty Column	Title
		No activities are currently published for this month.
No upcoming dates have been setup.